AtriCure Cash Flow Statement
NASDAQ: ATRCHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
AtriCure free cash flow
In fiscal 2025, AtriCure generated $57.3 million of operating cash flow and spent $9.1 million on capital expenditures. That left free cash flow of $48.3 million, a free-cash-flow margin of 9.0% of revenue. Free cash flow was up 6381.1% from the prior year's $745,000.
Summary generated from market data by MetaCap's automated system. Methodology
AtriCure cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -11.45M | -44.70M | -30.44M | -46.47M | 50.20M | -48.16M | -35.19M | -21.14M | -26.89M | -33.34M |
| Net Income growth (YoY) | — | — | — | -192.56% | — | — | — | — | — | — |
| Depreciation & Amortization | 12.09M | 11.21M | 9.46M | 8.06M | 7.53M | 7.87M | 7.42M | 7.24M | 7.76M | 7.66M |
| Stock-Based Compensation | 44.69M | 40.41M | 35.73M | 28.77M | 28.08M | 22.64M | 17.98M | 16.50M | 14.62M | 11.70M |
| Change in Working Capital | -1.83M | -16.37M | -13.96M | -16.58M | -1.38M | -6.65M | -2.45M | 1.64M | -2.42M | -5.05M |
| Operating Cash Flow | 57.33M | 12.20M | 4.48M | -22.14M | -13.78M | -19.87M | -15.81M | -4.17M | -8.94M | -15.12M |
| Capital Expenditures | -9.05M | -11.46M | -12.00M | -16.88M | -9.75M | -5.26M | -12.18M | -6.21M | -6.38M | -7.69M |
| Investing Cash Flow | -14.55M | 30.23M | 21.82M | 44.01M | 23.50M | -156.20M | -2.15M | -85.40M | 3.76M | -12.08M |
| Debt Issued | 0 | 61.21M | 0 | 0 | 5.00M | 0 | 20.00M | 17.38M | — | — |
| Debt Repaid | — | — | — | — | — | — | — | -1.75M | -1.69M | -439.00K |
| Financing Cash Flow | 1.18M | -3.60M | -32.00K | -7.06M | -7.64M | 189.39M | 14.37M | 100.18M | 2.76M | 27.70M |
| Net Change in Cash | 44.71M | 38.41M | 26.21M | 14.45M | 1.71M | 13.46M | -3.75M | 10.42M | -2.40M | 444.00K |
| Free Cash Flow | 48.28M | 745.00K | -7.51M | -39.02M | -23.53M | -25.13M | -27.99M | -10.38M | -15.33M | -22.81M |
This table shows 10 annual periods of AtriCure's cash flow statement, from FY 2025 back to FY 2016, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ATRC's reporting calendar. What is a cash flow statement?